The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: Genesys Capital

Monday Biotech Deal Review: July 25, 2011

Welcome to your Monday Biotech Deal Review for July 25, 2011.  Interesting tidbits from last week included the termination of the letter of intent relating to the proposed reverse-takeover transaction between Bradmer Pharmaceuticals and P1 Energy Corp., a distribution and marketing agreement between Valeant and Sanofi-aventis Canada, a $15M loan agreement between Protox Therapeutics and [...]

Q2 Venture Capital Numbers Do Not Look So Rosy in Canada

When Q2′s venture capital investment numbers came out for U.S. investment, healthcare/biotech investments were on top, beating out even IT investments in that period and generating some optimism. Dow Jones has released the worldwide Q2 venture capital numbers (H/T @startupcfo, and things do not look so rosy here in Canada: The overall number of VC [...]

Allostera’s $17m Deal Shows Canadian Venture Capital Funding is Available, Even as LPs Hold Back in the U.S.

Allostera Pharma Inc. anounced today that it closed a $17 million Series A round today, funded by four Canadian VCs: iNovia Capital, Genesys Capital, BDC Venture Capital with GO Capital, and Fonds Bio-Innovation s.e.c. The company is a spin-out of a University of Montreal-affiliated hospital and it has a platform to make peptide drugs that [...]

Follow

Get every new post delivered to your Inbox.

Join 84 other followers